Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase II clinical trial of talazoparib monotherapy for PALB2 mutation-associated advanced breast cancer. Gruber, J., Gross, W., McMillan, A., Ford, J. M., Telli, M. L. LIPPINCOTT WILLIAMS & WILKINS. 2021
View details for DOI 10.1200/JCO.2021.39.15_suppl.TPS1109
View details for Web of Science ID 000708120306163